Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 17-(1h-benzimidazol-1-yl)androsta-5,16-dien-3beta-ol
2. 3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene
3. Vn-124-1
1. 851983-85-2
2. Tok-001
3. Vn/124-1
4. Galaterone
5. Tok 001
6. Vn/124
7. Galeterone [usan]
8. Tok-001 (galeterone)
9. Vn 124
10. Vn-124-1
11. Wa33e149sw
12. (3s,8r,9s,10r,13s,14s)-17-(benzimidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1h-cyclopenta[a]phenanthren-3-ol
13. Galeterone (usan)
14. Vn-124
15. 3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene
16. (3s,8r,9s,10r,13s,14s)-17-(1h-benzo[d]imidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1h-cyclopenta[a]phenanthren-3-ol
17. Galeterone [usan:inn]
18. Unii-wa33e149sw
19. (3beta)-17-(1h-benzimidazol-1-yl)androsta-5,16-dien-3-ol
20. Tok-001(galeterone)
21. Tok-001; Galeterone
22. Galeterone [inn]
23. Galeterone [who-dd]
24. Schembl939234
25. Gtpl8638
26. 17-(1h-benzimidazol-1-yl)androsta-5,16-dien-3beta-ol
27. Chembl2105738
28. Galeterone, >=98% (hplc)
29. Chebi:177536
30. (3?)-17-(1h-benzimidazol-1-yl)androsta-5,16-dien-3-ol
31. 3beta-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene
32. Bcpp000040
33. Dtxsid101025602
34. Amy27882
35. Bcp02827
36. Ex-a1025
37. Zinc6718442
38. Bdbm50435990
39. Mfcd16660907
40. Akos005146524
41. Cs-0334
42. Db12415
43. Ac-26549
44. As-56204
45. Hy-70006
46. D10125
47. J-501178
48. Q5518498
49. Vn/124-1;tok-001;vn 124;tok001;tok 001
50. 3beta-hydroxy-17-(1h-benzimidazol-1-yl)-androsta-5,16-diene
51. 3beta-hydroxy-17-(1h-benzimidazol-1-yl)androsta-5,16-diene
52. Androsta-5,16-dien-3-ol, 17-(1h-benzimidazol-1-yl)-, (3beta)-
53. Androsta-5,16-dien-3-ol, 17-(1h-benzimidazol-1-yl)-, (3.beta.)-
| Molecular Weight | 388.5 g/mol |
|---|---|
| Molecular Formula | C26H32N2O |
| XLogP3 | 5.2 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 1 |
| Exact Mass | 388.251463648 g/mol |
| Monoisotopic Mass | 388.251463648 g/mol |
| Topological Polar Surface Area | 38 Ų |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 743 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 6 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Enzyme Inhibitors
Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)
ABOUT THIS PAGE
A Galeterone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Galeterone, including repackagers and relabelers. The FDA regulates Galeterone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Galeterone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Galeterone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Galeterone supplier is an individual or a company that provides Galeterone active pharmaceutical ingredient (API) or Galeterone finished formulations upon request. The Galeterone suppliers may include Galeterone API manufacturers, exporters, distributors and traders.
click here to find a list of Galeterone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Galeterone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Galeterone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Galeterone GMP manufacturer or Galeterone GMP API supplier for your needs.
A Galeterone CoA (Certificate of Analysis) is a formal document that attests to Galeterone's compliance with Galeterone specifications and serves as a tool for batch-level quality control.
Galeterone CoA mostly includes findings from lab analyses of a specific batch. For each Galeterone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Galeterone may be tested according to a variety of international standards, such as European Pharmacopoeia (Galeterone EP), Galeterone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Galeterone USP).
LOOKING FOR A SUPPLIER?
